The International Contrast Ultrasound Society (ICUS)

microbubbles-screenshot

 

 

 

 

 

 

 

ICUS has a new and exciting video that represents excellent promotion of CEUS imaging.

Aimed at the general public, the 2-minute video clip is due to be shown throughout December and January on American Airlines flights in that airline's in-flight, business TV entertainment.

While viewers will inevitably include those in the medical profession at all levels, the video is aimed at the 'person on the street', which of course also includes all those in healthcare management, administration and supply.  To view the video, click here.

The FDA has approved label changes for GE Healthcare's ultrasound contrast agent Optison, removing contraindications for use in patients with cardiac shunts and for administration by intra-arterial injection. Optison is the 1st contrast agent available in the U.S. to receive this label change, according to GE.

ICUS Co-President, Dr. Steven Feinstein commented:  “Up to one-third of our patients have known or suspected cardiac shunts and, thanks to this important FDA decision, they too will now have access to ultrasound contrast agents, which offer an inexpensive and radiation-free option for diagnostic imaging.”  He added,  “The International Contrast Ultrasound Society applauds the FDA for its decision, and believes it will benefit individual patients as well as our healthcare delivery system.”

Click here to read the full story

Expert lectures on Contrast-Enhanced Ultrasound (CEUS) for hospitals, physicians, sonographers, medical insurers and the public.

ICUS Grand Rounds is an independent educational program that features presentations and demonstrations by experts in the field of CEUS, with a special focus on clinical applications, techniques and safety. Call to arrange yours today! Click here for full details.

ICUS is pleased to note that the Mexican Federal Commission for Protection Against Sanitary Risk (COFEPRIS) has approved the contrast agent SonoVue in Mexico for use in echocardiography and Doppler ultrasonography. SonoVue is produced by Bracco and will be marketed in Mexico by Justesa Imagen Mexicana, S.A. de C.V.
 
ICUS applauds this action. We have long advocated for broader acceptance and appropriate use of ultrasound contrast agents, which have strong safety profiles and reduce overall health care costs without exposing patients to ionizing radiation.

ICUS Sponsors

ICUS gratefully acknowledges its 2017 sponsors:

dentons-logo2

silver-level

philips-icus-logo

samsung-logo

Toshiba Medical logo resized

siemens-new-original

mindray

ICUS Tweets

Follow Bubble Conference 2016 comment at #bubble2016
Connect live now to the 31st Annual Advances in Contrast Ultrasound "Bubble Conference" taking place in Chicago; https://t.co/67SmoW2GLn
FDA approves new liver imaging agent for adults and children; reduces exposure to harmful radiation. More at: https://t.co/3qa1vDFFhW

Contact ICUS

  • Address: 1900 K Street, N.W.
    Washington, DC 20006-1102, USA
  • Telephone: 202-408-6199

About ICUS

ICUS is the world’s only professional society exclusively devoted to contrast-enhanced ultrasound (CEUS) medical imaging technology.

Learn more...

You are here: Home ICUS News